Loading...
XNAS
NXL
Market cap9mUSD
Jul 09, Last price  
0.45USD
1D
8.89%
1Q
12.49%
IPO
-73.25%
Name

Nexalin Technology Inc

Chart & Performance

D1W1MN
XNAS:NXL chart
P/E
P/S
30.84
EPS
Div Yield, %
Shrs. gr., 5y
17.63%
Rev. gr., 5y
4.43%
Revenues
302k
+78.78%
207,383242,914144,0651,321,357110,748168,721301,647
Net income
-8m
L+8.08%
-5,021,190-3,403,486-6,078,004-1,697,816-4,648,709-7,607,182-8,222,181
CFO
-5m
L+25.69%
-678,336-863,474-1,076,791-2,215,699-3,835,384-3,944,390-4,957,658

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia. This device functions by emitting a unique, patented frequency waveform that elicits a beneficial response from mid-brain structures implicated in various mental health disorders. Furthermore, Nexalin is currently developing its "Generation 2" medical device, which is undergoing clinical trials for potential treatment of opiate-related substance abuse, chronic pain, Alzheimer's disease, and dementia.
IPO date
Sep 16, 2022
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT